ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979

In Legal Brawl, UPenn and Abramson Institute Allege Former Director Craig Thompson “Absconded” With Inventions

March 9, 2012

Academic Oncologists Reluctant To Give ESAs In Adjuvant Breast Cancer Setting.

December 7, 2007

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999